mayu sris  sarissa capital management lp  zoominfocom mayu sris  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member home  insider trading  mayu sris  profile mayu sris profile insider purchases insider sales news affiliations other at vivus inc vvus  director at emmaus life sciences inc none  home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved emmaus life sciences appoints new members to board of directors emmaus life sciences appoints new members to board of directors duane kurisu moni miyashita phillip satow and mayu sris join board as independent directors may    et from emmaus life sciences inc torrance calif may   prnewswire  emmaus life sciences inc a biopharmaceutical company dedicated primarily to the discovery development and commercialization of innovative treatments and therapies for rare and orphan diseases today announced the appointment of four new members to its board of directors duane kurisu chairman and ceo of aio moni miyashita senior advisor with a global consulting firm and former ibm vice president corporate development phillip satow chairman of the board of jds therapeutics and cofounder and former ceo of jds pharmaceuticals and mayu sris founding partner and managing director of sarissa capital management mr kurisu ms miyashita mr satow and mr sris join emmaus independent directors tracey doi chief financial officer of toyota motor sales usa and dr henry mckinnell chairman of the board of moodys corporation and former chairman and ceo of pfizer we welcome these four outstanding new board members at an exciting time for our company having recently completed our phase  clinical trial for the treatment of sickle cell disease said dr yutaka niihara md mph founder and ceo of emmaus life sciences collectively their depth of experience in business strategy management and the pharmaceutical industry will strengthen our company as we position it for the next phase of growth we are delighted that duane moni phil and mayu have joined the board said dr henry mckinnell chairman of the board of emmaus life sciences  i look forward to working with them to guide the company as it works to bring the first new and potential widelyavailable sickle cell disease treatment to patients in more than  years following is biographical information on the new emmaus directors mr kurisu is the chairman chief executive officer and owner of aio group a holding company for consumer brands focused on hawaii and the pacific in the areas of media sports and food he also is the owner director and vice president of nutricopia inc a nutraceuticals company owner manager and chief executive officer of pacificbasin communications llc a publishing company and owner and a manager of kf  llc a real estate company mr kurisu has served on the board of central pacific financial corp a bank holding company since january   and also served as a director of central pacific financial corp from september  to may  mr kurisu also is the owner director and vice president of hawaii winter baseball inc a professional baseball league in hawaii he holds bba and mba degrees from the university of hawaii ms miyashita is an independent advisor on mergers and acquisitions at a global consulting firm she previously held a more than  year career at ibm where she served as vice president corporate development including  years in executive ma roles as vice president ma strategy and investments managing director of ma integration and director of corporate development asia pacific headquartered in tokyo ms miyashita serves on the board of trustees of the childrens hospital of philadelphia the executive advisory board of the university of denvers daniels school of business the international executive advisory council of the navigators and the board of directors of the usjapan council ms miyashita holds a bs degree in marketing from the university of colorado leeds school of business and a mba from the university of denver daniels school of business mr satow is currently chairman of the board of directors of jds therapeutics llc which markets proprietary healthcare products to physicians healthcaredelivery networks and other healthcare professionals he was cofounder chairman and ceo of jds pharmaceuticals llc a specialty pharmaceutical company focused in the fields of psychiatric and womens health treatments jds pharmaceuticals was sold to noven pharmaceuticals inc in  prior to founding jds pharmaceuticals mr satow served as executive vice president of forest laboratories inc president of forest pharmaceuticals inc and as a member of forests board of directors prior to joining forest mr satow served as vice president and general manager of the wallace laboratories division of carter–wallace inc in addition he has held executive positions at pfizer including director of marketing with pfizer laboratories and vice president of pfizer europe mr satow holds a ba degree from columbia college and an ma degree in economics from georgetown university mr sris is a founding partner and managing director of sarissa capital management lp a hedgefund firm he most recently served as an investment analyst at icahn capital an investment company from  to  and as a consultant in  where he contributed to all aspects of the activist investing process with the goal of proactively creating substantial value prior to icahn capital mr sris served as a consultant at bain  company a management consulting firm from  to  working with both corporate and private equity clients  previously he served as an investment banker at wasserstein perella  company an investment bank where he advised technology clients on ma transactions in addition from  to  mr sris was a member of the board of directors of publicly traded viskase companies inc  mr sris received his ab degree from brown university about emmaus life sciences inc emmaus life sciences is dedicated to the discovery development and commercialization of innovative treatments and therapies for rare and orphan diseases for more information please visit wwwemmauslifesciencescom forwardlooking statements this press release contains forwardlooking statements as that term is defined in the private securities litigation reform act of  regarding the research development and potential commercialization of pharmaceutical products such forwardlooking statements including but not limited to helping position emmaus for the next phase of the companys growth and working to bring a sickle cell disease treatment to patients are based on current expectations and involve inherent risks and uncertainties including factors that could delay divert or change any of them and could cause actual outcomes and results to differ materially from current expectations additional risks and uncertainties are described in reports filed by emmaus life sciences inc with the us securities and exchange commission including its annual report on form k for the year ended december   and quarterly report on form q for the period ended march   emmaus is providing this information as of the date of this press release and does not undertake any obligation to update any forwardlooking statements as a result of new information future events or otherwise contacts media lori teranishi for emmaus life sciences inclteranishiiqprinccom investorsmatt sheldon roger pondel for emmaus life sciences incinvestorpondelcom source emmaus life sciences inc related links httpwwwemmausmedicalcom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more nov    et preview emmaus life sciences to present phase  sickle cell disease trial data at th american society of hematology annual meeting mar    et preview emmaus life sciences anuncia resultados principales positivos de su ensayo clínico de fase  para la enfermedad de células falciformes my news release contains wide tables view fullscreen read more feb    et emmaus life sciences inc to present at los angeles biomedical feb    et emmaus life sciences inc receives notice of allowance for feb    et emmaus life sciences inc receives notice of allowance for us looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search insider trading  sris mayu  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  sris mayu select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view disposition  pm nana vivus inc vvus sris mayudirector   direct view exercise  pm nana vivus inc vvus sris mayudirector   direct view option award  pm nana vivus inc vvus sris mayudirector   direct view option award  pm na vivus inc vvus sris mayudirector   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  mayu sris  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors mayu sris check out list of companies and businesses related to mayu sris find out mayu sris address and contact details view other people related to mayu sris  coworkers colleagues companions etc address  s western ave suite  torrance  ca companies related to mayu sris cikcompany namepositioncompany addressvivus incdirector  e hamilton avenue suite  campbell emmaus life sciences incdirector  hawthorne blvd suite  torrance  mayu sris on the web persons related to mayu sris  vivus incnamepositioncitymichael j astruedirector mountain viewrolf e bassberlinjon c biro owner houstonj martin carrolldirector mountain viewj martin carrolldirector mountain viewcharles j casamentodirector mountain viewcharles j casamentodirector mountain viewwang changjinvp business development mountain viewsamuel f colindirector mountain viewwesley dayvp clinical development mountain viewwesley dayvp clinical development mountain viewwesley dayvp clinical development mountain viewalexander j dennerdirector greenwichalexander j dennerdirector greenwichjohn w dietrichvice president r  d john w dietrichvice president r  d mountain viewfirst biomed management associates llcnew yorkmanhattan co firstnew yorkseth hz fischerchief executive officer san diegoseth hz fischerchief executive officer mountain viewlori forrestvp operations  general mgr lakewoodneil gesundheitvp chief medical officer neil gesundheitmountain viewjacob pieter kastelein johannesdirector mountain viewmelvin l keatinglivingstonthomas braxton kingsalt lake cityconan laughlinbostonconan laughlinbostonconan laughlinbostonmark b logandirector mark b logandirector mountain viewmark b logandirector mountain viewernest mariodirector mountain viewguy p marshvp operations  general mgr guy p marshvp operations and general mgr mountain viewguy p marshvp operations and general mgr mountain viewguy p marshvp us operations  gm mountain viewmichael ny millerchief commercial officer mountain viewmichael patrick millermountain viewjohann noor mohamedmountain viewtimothy e morrisvp finance and cfo union citytimothy e morrisvp finance and cfo mountain viewtimothy e morrisvp finance and cfo mountain viewjames r nickelvice president clinical james r nickelmountain viewterry nidavp worldwide marketing terry nidavp worldwide marketing mountain viewnorth tide capital llc owner bostonnorth tide capital master lpbostonnorth tide capital master lpbostondavid y nortondirector east brunswickdavid y nortonprincetondavid y nortondirector mountain viewdavid y nortonmountain viewmark k okichief financial officer  cao mountain viewlee perryvp  chief accounting officer mountain viewvirgil a placechairman  cso virgil a placechief scientific officer mountain viewvirgil a placechief scientific officer mountain viewjorge md plutzkydirector mountain viewjorge md plutzkydirector mountain vieweric w robertsdirector new yorkmario m rosatidirector palo altomario m rosatisecretary palo altomario m rosatidirector palo altoherm rosenmandirector san diegoherm rosenmansan diegoherm rosenmandirector mountain viewsvai s sanfordchief financial officer mountain viewsvai s sanfordinterim cfo mountain viewsvai s sanfordcfo  chief accounting officer mountain viewsarissa capital domestic fund lpgreenwichsarissa capital domestic fund lpgreenwichsarissa capital management lpgreenwichsarissa capital management lpgreenwichsarissa capital offshore master fund lpgreenwichsarissa capital offshore master fund lpgreenwichallan shawdirector new yorklinda m dairiki shortliffedirector palo altolinda m dairiki shortliffedirector mountain viewjohn l slebirsvp business development  gc mountain viewjohn l slebirsvp  general counsel mountain viewjohn l slebirsvp business development  gc mountain viewmayu srisdirector torrancegraham strachandirector graham strachandirector mountain viewlarry j straussvice president finance  cfo peter y tamsenior vp commerical  peter y tampresident mountain viewsantosh t varghesechief medical officer mountain viewrichard w walliserleland f wilsonpresident  ceo menlo parkleland f wilsonchief executive officer mountain viewrobert n wilsondirector mountain viewrobert n wilsonmountain viewrobert n wilsondirector mountain viewcarol zoltowskivice president regulatory carol zoltowskimountain viewanthony p zookchief executive officer mountain viewpersons related to mayu sris  emmaus life sciences incnamepositioncityafh holding  advisory llcbeverly hillsosborne jr alfredtorranceheshmatpour amirbeverly hillsheshmatpour amirtorrancetimothy braselgreenwood villagetimothy braselvice president auroramaurice j dewaldlos angelesmaurice j dewalddirector los angelesmaurice j dewalddirector torrancemaurice j dewalddirector torrancetracey doidirector torrancetracey doidirector torrancegriffin ventures ltdbeverly hillsmckinnell henrytorrancemckinnell henrytorranceamir f heshmatpourdirector beverly hillsamir f heshmatpourdirector beverly hillsamir f heshmatpourdirector beverly hillsamir f heshmatpourdirector beverly hillsamir f heshmatpourpresident and secretary beverly hillszwicker iantorrancekuwahara jontorrancekpm tech co ltdgyeonggidoduane k kurisudirector torrancejon kuwaharadirector torrancetran lantorrancetran lantorrancetran lantorrancesangho steve leetorrancewillis c leevice chairman  coo torrancewillis c leedirector torrancewillis c leetorrancewillis c leechief operating officer torrancepeter ludlumchief business officer torrancepeter ludlumevp and cfo torranceosato masaharutorrancedewald mauricetorrancedewald mauricetorrancehenry a mckinnelldirector torrancehenry a mckinnelldirector torranceakiko moni miyashitadirector torranceyasushi nagasakisenior vp finance torranceyasushi nagasakisenior vp finance torrancesoomi niiharatorranceyutaka niiharachairman and ceo torranceyutaka niiharapresident and ceo torrancemasaharu osatodirector torrancealfred e osborne jrlos angelesalfred e osborne jrdirector los angelesludlum petertorranceludlum petertorrancephillip m satowtorrancephillip m satowdirector torrancemayu srisdirector torrancebrasel timothybeverly hillsdoi traceytorrancedoi traceytorrancedoi traceytorrancelan t tranchief administrative officer torrancelan t tranchief administrative officer torrancelan t tranchief administrative officer torrancesteve b warnecketorrancelee willistorrancelee willistorrancelee willistorrancedouglas wilmoretorrancenagasaki yasushitorrancenagasaki yasushitorrancenagasaki yasushitorranceniihara yutakatorranceniihara yutakatorranceniihara yutakatorranceian harvey zwickerdirector torrance vvus sec filings report for   news quantified × e e       secreport form  vivus inc for sep  filed by sris mayu vivus vvus  more company research source sec edgar last vivus earnings   pm check earnings report impact snapshot event time vvus last price price change price change  volume shares max up max down volume ratio  performance comparison updated event day stock performance from the time of news release until the following pm et market close last price at news event since event multiday stock performance from the time of the news release event day stock performance from the time of news release until the following pm et market close last price at news event since event multiday stock performance from the time of the news release last price vwap high max up high low max down low  post news range  price change price change percentage sp  spx  volume ratio  volume shares ticks avg shares per trade   vvuss stock demonstrates remarkable incline of  from share to share since news hit the wires via news quantified click to share event day event day chart will not be displayed beyond day period of the event performance since event time and velocity analysis be the first to know opt in for alerts from news quantifed sign up today in short news quantified specializes in matching financial news with market data weve analyzed s of millions of news events and know exactly which ones have an outsized impact on stock prices so every single time a news item is released we know exactly what the average effect will be on a particular stock subscribe stay in the know news product updates and promotions subscribe contact us  n pima rd f scottsdale az  email infonewsquantifiedcom support disclaimers privacy policy terms of use contact us information home about us services analyst actions elite institutions market impact report contact blog latest posts how to find big gains on positive earnings reports one monday three great trades these three companies are set to crush wall street’s expectations three diverse plays from the  trading session using high volume news to find big gains three pharma plays copyright ⓒ news quanitifed llc  in short news quantified specializes in matching financial news with market data weve analyzed s of millions of news events and know exactly which ones have an outsized impact on stock prices so every single time a news item is released we know exactly what the average effect will be on a particular stock latest posts how to find big gains on positive earnings reports one monday three great trades these three companies are set to crush wall street’s expectations three diverse plays from the  trading session using high volume news to find big gains three pharma plays information home about us services analyst actions elite institutions market impact report contact blog support disclaimers privacy policy terms of use contact us contact us  n pima rd f scottsdale az  email infonewsquantifiedcom subscribe stay in the know news product updates and promotions subscribe copyright ⓒ news quanitifed llc  sris mayu  vivus insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailssris mayuvivus vvusdirector not rankedsris mayus performancesris mayu has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked sris mayus trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datevvusvivusdirectoruninformative buyjan  sris mayu has not reported any informative transactions for vvus therefore performance cannot be measured track record datetransactionamountno of sharesprice per shareprofitform  jan   uninformative buy k   na dec   uninformative buy    na nov   uninformative buy    na show moresee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by sris mayu insider insider trades  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  ownership  insider trades  individual insiders insider trades of sris mayu click on the column header to resort ascending ▲ or descending ▼ individual insider trades company relation last date ▼ type tran ownertype shares traded last price shares held vivus inc other  form  disposition non open market direct    vivus inc other  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    vivus inc director  form  disposition non open market direct    highest rated articles of last week shareholders approve major structural change to top performing yatra attains leadership position in corporate travel with the mitel to acquire shoretel  quick facts miller heiman group selects calliduscloud datahug for pipeline tractor supply company reports second quarter results view all highest rated most rated stocks of last week rated stocks for nasdaq nyse and amex symbol  ratings consensus aapl  bullish of  ratings rate it fb  bullish of  ratings rate it tsla  bullish of  ratings rate it msft  bullish of  ratings rate it goog  bullish of  ratings rate it jpm  bullish of  ratings rate it gm  bullish of  ratings rate it bac  bullish of  ratings rate it nflx  bullish of  ratings rate it intc  bullish of  ratings rate it more most rated stocks closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex